Artificial Intelligence-Based Assessment of Endosseous Lesions
Recruiting now · Not applicable
Conditions studied: Maxillary Cyst, Mandibular Cyst
In brief
Despite these advances, CBCT interpretation remains largely qualitative and dependent on the clinician's experience. Conventional evaluation is based on two-dimensional slices and linear measurements, which may underestimate lesion complexity and spatial distribution. Recent developments in Artificial Intelligence in Medicine have introduced automated image segmentation tools capable of identifying lesion boundaries and calculating volumetric data. These technologies allow a transition from subjective assessment to objective, reproducible quantification. The potential clinical advantages include: * Objective measurement of lesion size (volume in mm³) * Improved surgical planning * Enhanced prediction of anatomical involvement * Reduction of diagnostic errors * Standardization of follow-up and outcome assessment Therefore, the aim of the present study was to evaluate the clinical impact of AI-based segmentation and volumetric analysis of endosseous lesions compared to conventional CBCT interpretation.
Key facts
- Study ID
- NCT07505485
- Run by
- University of Bari Aldo Moro
- People needed
- 10
- Starts
- 2026-04-01
- Expected to finish
- 2026-05-01
- Last updated by the study team
- 2026-04-15
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Good health according to the System of the American Society of Anesthesiology
- Aged older than 18 years
- No general medical contraindication for surgery
You may not qualify if…
- Smoking more than 15 cigarettes a day
- Pregnancy
- Acute infections
Where it is running
- University of Bari Aldo Moro — Bari, Italy (enrolling)
- Dr. Giuseppe D'Albis — Bari, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.